Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...

The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...

FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings ...

Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...

Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...

Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...

America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...

A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...

The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...